Integris Medtech Limited IPO DRHP
Integris Medtech is a diversified India-based global medical products and laboratory solutions company with expertise in developing, manufacturing, commercializing and marketing a broad, integrated portfolio of healthcare solutions. Its offerings span cardiovascular devices, clinical diagnostics and scientific laboratory solutions, catering to varied medical and research requirements. The Company operates manufacturing facilities in India, Germany and the Netherlands, and collaborates with global partners to support its product portfolio. As of June 30, 2025, Integris Medtech’s medical devices and laboratory solutions were marketed and distributed across more than 65 countries, reflecting its expanding international presence and operational scale.
Integris Medtech IPO Objects
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings, interest accrued & prepayment penalties, as applicable
- The wholly-owned Subsidiaries, namely, Translumina Therapeutics, Transhealth & HaleMed Medical Private Limited
- The Company’s step-down subsidiaries include CPC Diagnostics, Chemopharm, Chemoscience, Lifeline Diagnostics, Hausen Bernstein, Medigene, & Research Instruments.
- General corporate purposes
Integris Medtech IPO Details
Price Band₹ |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹925.00 Cr (0.00 Shares) |
Offer For Sale₹0.00 (2.17 Cr Shares) |
Total Issue₹925.00 Cr (2.17 Cr Shares) |
Face Value₹1 per equity share |
Category Allocation
| Particulars | Allocation |
|---|---|
| QIB | Not less than 75% of Net Offer |
| Big HNIs (NII) | Not more than 10% of Net Offer |
| Small HNIs (NII) | Not more than 5% of Net Offer |
| Retail | Not more than 10% of Net Offer |
Integris Medtech IPO Financials
| Particulars | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Revenue | 1,902.47 | 1,553.38 | 1,348.10 |
| PAT | 70.68 | -4.88 | -40.54 |
| Net Worth | 2,752.52 | 2,681.02 | 2,629.52 |
| Borrowings | 1,729.46 | 813.10 | 556.54 |
| Assets | 3,641.34 | 2,989.20 | 2,553.87 |
| NAV (₹) | 316.09 | 313.11 | 323.91 |
| EPS (₹) | 5.82 | -1.38 | -5.99 |
The financial information presented is on a consolidated basis.
Key Performance Indicators
| KPI | VALUES |
|---|---|
| EBITDA | 16.26% |
| PAT | 3.72% |
| ROE | 5.35% |
| ROCE | 14.51% |
- All the data pertains to FY 2024-25.
- PE, PB, and market capitalization are calculated based on the Upper Price Band.
Promoter Details
| Name | Shareholding |
|---|---|
| Evercure Holdings Pte. Ltd. | 28.85% |
| Medicore Holdings Pte. Ltd. | 33.93% |
| Gurmit Singh Chugh | 10.23% |
| Punita Sharma | 10.23% |
| Total | 83.24% |
Management Details
| Name | Designation |
|---|---|
| Annaswamy Vaidheesh | Chariman |
| Probir Das | CEO |
| Hemant Sultania | CFO |
Company Details
Name: Integris Medtech Limited
Address: 1st Floor, Metro Tower LSC, M.O.R Land, New Rajinder Nagar, New Delhi 110 060 Delhi, India
Number: +91 120 4531422
Email: investors@integrismedtech.com
Website: www.integrismedtech.com
Book Running Lead Managers (BRLMs)
RTAs
KFin Technologies
Visit WebsiteFrequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Integris Medtech IPO is a Mainboard IPO having an issue size of Rs. ₹925.00 Crs. Integris Medtech IPO is priced at ₹ - ₹ per share. The issue opens on 13 Mar 26 and closes on 13 Mar 26.
Integris Medtech IPO opens on 13 Mar 26 and closes on 13 Mar 26.
The estimated Grey Market Premium of Integris Medtech IPO is ₹0 per share (-).
The minimum lot size of Integris Medtech IPO is shares & the minimum application amount is Rs. 0.
The allotment date of Integris Medtech IPO is 13 Mar 26.
The listing date of Integris Medtech IPO is 13 Mar 26.
Integris Medtech IPO is subscribed -.
Integris Medtech IPO is priced at ₹ - ₹ per share.
Click the allotment link on Integris Medtech IPO page of IPO360.
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Integris Medtech IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
